BSECompany Update11 Aug 2026 · 11 Aug 2026, 06:23 pm

Newspaper Publications

Jubilant Pharmova Ltd · 530019

✦ AI SummaryResults

Jubilant Pharmova Ltd has published unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in the Financial Express and Hindustan & Jansatta newspapers.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

b950b041-3a72-47f2-ab61-5ce7b3c03d54.pdf

pdf

Download →
View document text
August 11, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Submission of copies of published Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 Dear Sirs, Pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Financial Express (English) and Hindustan & Jansatta (Hindi) newspapers dated August 11, 2026, in which Quick Response Code (QR Code) and the details of the webpage where complete Unaudited financial results of the Company for the quarter ended June 30, 2026, accessible to the Investors, have been published. The aforesaid results were approved by the Board of Directors in their meeting held on August 10, 2026. We request you to take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl: As above